"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SKIN.
| Descriptor ID |
D012878
|
| MeSH Number(s) |
C04.588.805 C17.800.882
|
| Concept/Terms |
Skin Neoplasms- Skin Neoplasms
- Neoplasms, Skin
- Neoplasm, Skin
- Skin Neoplasm
Cancer of Skin- Cancer of Skin
- Skin Cancers
- Cancer of the Skin
- Skin Cancer
- Cancer, Skin
- Cancers, Skin
|
Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".
This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 29 | 7 | 36 |
| 1995 | 34 | 4 | 38 |
| 1996 | 26 | 7 | 33 |
| 1997 | 36 | 4 | 40 |
| 1998 | 49 | 4 | 53 |
| 1999 | 31 | 6 | 37 |
| 2000 | 48 | 10 | 58 |
| 2001 | 51 | 3 | 54 |
| 2002 | 65 | 5 | 70 |
| 2003 | 65 | 12 | 77 |
| 2004 | 48 | 6 | 54 |
| 2005 | 61 | 10 | 71 |
| 2006 | 76 | 11 | 87 |
| 2007 | 69 | 6 | 75 |
| 2008 | 81 | 5 | 86 |
| 2009 | 66 | 6 | 72 |
| 2010 | 81 | 10 | 91 |
| 2011 | 103 | 9 | 112 |
| 2012 | 88 | 7 | 95 |
| 2013 | 83 | 10 | 93 |
| 2014 | 82 | 20 | 102 |
| 2015 | 83 | 10 | 93 |
| 2016 | 78 | 12 | 90 |
| 2017 | 108 | 8 | 116 |
| 2018 | 97 | 8 | 105 |
| 2019 | 78 | 6 | 84 |
| 2020 | 99 | 8 | 107 |
| 2021 | 85 | 6 | 91 |
| 2022 | 82 | 2 | 84 |
| 2023 | 72 | 3 | 75 |
| 2024 | 56 | 9 | 65 |
To return to the timeline,
click here.
Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas. J Immunother Cancer. 2024 Nov 12; 12(11).
-
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance. JCO Precis Oncol. 2024 Nov; 8:e2400375.
-
Small-Molecule CCR4 Antagonists in Cutaneous T-cell Lymphoma. Cancer Res Commun. 2024 Oct 01; 4(10):2756-2765.
-
Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early-Stage Malignant Melanoma. Cancer Med. 2024 Oct; 13(19):e70313.
-
Epidemiology of dermatofibrosarcoma protuberans among Asian-American sub-groups: a population-based study of the surveillance, epidemiology, and end results (SEER) program. Arch Dermatol Res. 2024 Sep 26; 316(9):637.
-
Treatment outcomes following partial shave biopsy of atypical and malignant melanocytic tumors in pediatric patients. Melanoma Res. 2024 Dec 01; 34(6):544-548.
-
Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel. J Drugs Dermatol. 2024 09 01; 23(9):774-781.
-
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and S?zary Syndrome. Transplant Cell Ther. 2024 Nov; 30(11):1047-1060.
-
Nail technicians as partners in early melanoma detection: bridging the knowledge gap. Arch Dermatol Res. 2024 Aug 29; 316(8):586.
-
Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas): Single-Institution Study of 95 Surgical Patients. Ann Surg Oncol. 2024 Nov; 31(12):7950-7956.